Development of machine learning-based drug repurposing pipeline against SARS-CoV-2 and human proteome
Implementing Organization
Principal Investigator
Dr Kamal Rawal
Associate Professor
|
Amity University, Uttar Pradesh
About
The study intends to develop artificial intelligence (AI) driven, integrative, antiviral drug repurposing platform.
Patents
NA
Achievements
NA
Outcome / Output
A web enabled resource for COVID-19 datasets, information and software has been created for the benefit of the scientific community. Further, a patient-centric cloud-based system to capture side effects and therapeutics of existing drugs used for COVID-19 treatment has been deployed.
Disclaimer:
Information available on this portal is sourced from various organizations and is provided for informational purposes only. Users are advised to verify details from the respective official sources.
Please enter your details
Please provide your name and email to continue. Your details are saved in this browser for future use.
Latest Updates
Loading…
⚠️
You are leaving this website
You are about to be redirected to an external website that is not operated by
India Science, Technology & Innovation (ISTI) Portal.
Associate Professor
Amity University, Uttar Pradesh
Acces sibility Controls